Clinical evaluation of cefluprenam for treatment of respiratory infections

Kaoru Shimokata; Satoshi Ichiyama; Hideo Saka; Masashi Yamamoto; Masaaki Nagatake; Tetsuya Yagi; Takanao Murate; Kazuyoshi Imaizumi; Eishi Takagi; Naoko Yurikusa

doi:10.11250/chemotherapy1995.43.Supplement4_298

Clinical evaluation of cefluprenam for treatment of respiratory infections

Kaoru Shimokata, Satoshi Ichiyama, Hideo Saka, Masashi Yamamoto, Masaaki Nagatake, Tetsuya Yagi, Takanao Murate, Kazuyoshi Imaizumi, Eishi Takagi, Naoko Yurikusa

Research output: Contribution to journal › Article › peer-review

Abstract

Clinical efficacy and safety of cefluprenam (CFLP) were evaluated in 11 patients with respiratory infections. CFLP were administered intravenously 0.5g or 1.0g twice daily. The duration of treatment ranged from 4 to 17 days. Clinical efficacy was excellent in 4, good in 6 and poor in one patient. Skin rash was observed in 1 patient, and abnormal laboratory findings were observed in 2 patients. The results suggest that CFLP is useful for treatment of respiratory infections.

Original language	English
Pages (from-to)	298-301
Number of pages	4
Journal	Japanese Journal of Chemotherapy
Volume	43
DOIs	https://doi.org/10.11250/chemotherapy1995.43.Supplement4_298
Publication status	Published - 1995
Externally published	Yes

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmacology (medical)

Access to Document

10.11250/chemotherapy1995.43.Supplement4_298

Cite this

@article{fc77d332e99b4271bdee923b3102efdb,

title = "Clinical evaluation of cefluprenam for treatment of respiratory infections",

abstract = "Clinical efficacy and safety of cefluprenam (CFLP) were evaluated in 11 patients with respiratory infections. CFLP were administered intravenously 0.5g or 1.0g twice daily. The duration of treatment ranged from 4 to 17 days. Clinical efficacy was excellent in 4, good in 6 and poor in one patient. Skin rash was observed in 1 patient, and abnormal laboratory findings were observed in 2 patients. The results suggest that CFLP is useful for treatment of respiratory infections.",

author = "Kaoru Shimokata and Satoshi Ichiyama and Hideo Saka and Masashi Yamamoto and Masaaki Nagatake and Tetsuya Yagi and Takanao Murate and Kazuyoshi Imaizumi and Eishi Takagi and Naoko Yurikusa",

year = "1995",

doi = "10.11250/chemotherapy1995.43.Supplement4\_298",

language = "English",

volume = "43",

pages = "298--301",

journal = "Japanese Journal of Chemotherapy",

issn = "1340-7007",

publisher = "Japanese Society of Chemotherapy",

}

TY - JOUR

T1 - Clinical evaluation of cefluprenam for treatment of respiratory infections

AU - Shimokata, Kaoru

AU - Ichiyama, Satoshi

AU - Saka, Hideo

AU - Yamamoto, Masashi

AU - Nagatake, Masaaki

AU - Yagi, Tetsuya

AU - Murate, Takanao

AU - Imaizumi, Kazuyoshi

AU - Takagi, Eishi

AU - Yurikusa, Naoko

PY - 1995

Y1 - 1995

N2 - Clinical efficacy and safety of cefluprenam (CFLP) were evaluated in 11 patients with respiratory infections. CFLP were administered intravenously 0.5g or 1.0g twice daily. The duration of treatment ranged from 4 to 17 days. Clinical efficacy was excellent in 4, good in 6 and poor in one patient. Skin rash was observed in 1 patient, and abnormal laboratory findings were observed in 2 patients. The results suggest that CFLP is useful for treatment of respiratory infections.

AB - Clinical efficacy and safety of cefluprenam (CFLP) were evaluated in 11 patients with respiratory infections. CFLP were administered intravenously 0.5g or 1.0g twice daily. The duration of treatment ranged from 4 to 17 days. Clinical efficacy was excellent in 4, good in 6 and poor in one patient. Skin rash was observed in 1 patient, and abnormal laboratory findings were observed in 2 patients. The results suggest that CFLP is useful for treatment of respiratory infections.

UR - https://www.scopus.com/pages/publications/0029618352

UR - https://www.scopus.com/inward/citedby.url?scp=0029618352&partnerID=8YFLogxK

U2 - 10.11250/chemotherapy1995.43.Supplement4_298

DO - 10.11250/chemotherapy1995.43.Supplement4_298

M3 - Article

AN - SCOPUS:0029618352

SN - 1340-7007

VL - 43

SP - 298

EP - 301

JO - Japanese Journal of Chemotherapy

JF - Japanese Journal of Chemotherapy

ER -

Clinical evaluation of cefluprenam for treatment of respiratory infections

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this